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Abstract Defects in the dystrophin complex (DC) underlie
several human genetic disorders, but our dissection of its function
is complicated by potential redundancy of the multiple vertebrate
isoforms of most DC components. We here complete our previous
description of Drosophila dystrophin, and show that the fly
retains all essential components of the DC, but with substantially
less diversity. Seventeen known human components (three
dystrophin-related proteins, two dystrobrevins, five sarcoglycans,
five syntrophins, one dystroglycan and one sarcospan) appear to
be reduced to eight in Drosophila (one, one, three, two, one and
none, respectively). The simplicity of this system recommends it
as a model for its human counterpart. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Gene duplication, a¡ording an opportunity for functional
divergence, is thought to be of major importance in metazoan
evolution. Comparisons of gene families imply two major
phases of duplication since vertebrate origins [1]. As a result,
a single invertebrate gene is often orthologous to the last
common ancestor of a substantial vertebrate gene family.
Concordant with this ¢nding, we have previously shown
that invertebrates from distinct phyla (nematodes, arthropods,
mollusks, echinoderms and protochordates) each have a single
protein, orthologous to the last common ancestor of three
related vertebrate proteins, dystrophin, utrophin and DRP2
[2].
Duchenne, Becker and the limb-girdle muscular dystrophies
are human myopathies caused by disruptions in genes encod-
ing dystrophin [3] or other components of the dystrophin
complex (DC; Fig. 1A) expressed in skeletal muscle cells.
Together with sarcospan and dystroglycan, the known verte-
brate DC comprises three other protein families: the syntro-
phins (K1, L1, L2, Q1 and Q2), dystrobrevins (K and L) and
sarcoglycans (K, L, Q, N and O). In its entirety, the DC is
considered important for maintaining the integrity of skeletal
and cardiac muscle cells, with dystrophin serving to increase
stability of the sarcolemma during muscular contraction [4,5].
Roles in intracellular signalling have also been proposed, in-
volving neuronal nitric oxide synthase (nNOS) [6^8], voltage-
gated sodium channels [9,10] and acetylcholine receptors
[11,12], yet it is not clear as to how these might contribute
towards normal dystrophin function in vertebrate muscle and
other tissues.
The relatively simple and well-characterised musculature
and nervous system of Caenorhabditis elegans have allowed
this invertebrate to be used in recent studies for the investiga-
tion of DC function. It has been shown that the C. elegans
genome contains homologues of vertebrate dystrobrevins and
syntrophins, and that their interaction with dystrophin is evo-
lutionarily conserved [13]. Mutations in dys-1 (dystrophin or-
thologue) or dyb-1 (dystrobrevin orthologue) are shown to
result in cholinergic signalling defects [14^16]. Unlike Droso-
phila melanogaster, no homologues of vertebrate NOS or volt-
age-gated sodium channels have been identi¢ed in the C. ele-
gans genome. The signi¢cance of interactions between these
proteins and syntrophins is unknown, though it has been pro-
posed that impaired nitric oxide signalling can contribute to-
wards a cardiac and skeletal myopathy [6,7].
As with the nematode, the genome project has now been
completed for D. melanogaster [17]. Consequently, we have
completed our characterisation of the gene encoding the £y
dystrophin homologue and further identi¢ed expressed se-
quence homologues of all associated vertebrate proteins.
The £y retains the components and presumably the function
of the complete DC. With the reduced level of DC complexity
shown by phylogenetic analysis (Fig. 2), and its experimental
amenability, we propose D. melanogaster as a suitable inver-
tebrate model for the study of DC biology.
2. Methods: characterisation of Drosophila orthologues
The Berkeley and European Drosophila genome databases
were searched for sequences homologous to human compo-
nents of the dystrophin-associated complex (dystrophin, dys-
trobrevins, syntrophins, sarcoglycans, dystroglycan and sarco-
span) using TBLASTN. Fly sequences encoding homologous
open reading frames were used to design primers (sequences
available on request) for reverse transcription-polymerase
chain reaction, rapid ampli¢cation of cDNA ends and se-
quencing. Where possible, expressed-sequence tag contigs
were also used for exon characterisation. Protein sequences
were aligned using CLUSTALW v1.4 [18], and phylogenetic
analysis for each family of proteins was performed using
greatest regions of continuous homology between human
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 2 0 1 8 - 4
*Corresponding author. Fax: (44)-20-79554644.
E-mail: roland.roberts@kcl.ac.uk
1 New database accession numbers: AF277386, AF277387,
AF277388, AF277389, AF277390, AF277391, AF277392, AF277393.
FEBS 24129 22-9-00 Cyaan Magenta Geel Zwart
FEBS 24129 FEBS Letters 482 (2000) 13^18
and orthologues in the neighbour-joining option of CLUS-
TAL. Trees were drawn using TreeView [19] and modi¢ed
for presentation whilst maintaining branch length and topol-
ogy.
3. The conservation of dystrophin in Drosophila
Residing within genomic sca¡old clone AE003726, we have
found the Drosophila orthologue of dystrophin (DmDYS) to
be encoded by an unusual gene of at least 130 kb in length (we
could not establish the size of one intron), with 31 introns
ranging from 61 bp up to 48 kb. No genes were detected
within the large introns using NIX to apply a range of bio-
informatic gene-detecting algorithms, and the reason for the
large size of this gene remains as enigmatic as the human
dystrophin gene size. The intron/exon structure is virtually
unrelated to that of the human gene (one coding exon is an
extraordinary 3.5 kb in length). The 2.7 Mb human dystro-
phin gene encodes a large protein of 3685 amino acids in
length, comprising four main sections: an actin-binding N-
terminus, a rod-like spectrin repeat region, a cysteine-rich re-
gion (containing a WW domain, four EF-hands and a ZZ
domain) and a C-terminal region [3,20]. Using the highly con-
served C-terminal end, we previously isolated a similar se-
quence representative of the sole Drosophila dystrophin-like
protein [2]. Our recent characterisation of the complete coding
sequence for DmDYS reveals a shorter protein (3124 residues)
that retains all four sections distinctive of its vertebrate coun-
terpart. The cysteine-rich and C-terminal regions remain the
most highly conserved part of DmDYS, with an identity of
54% between human and £y. These regions of the vertebrate
protein contain sequences known to interact with L-dystrogly-
can, the syntrophins and dystrobrevins.
An alignment of the N-terminus (Fig. 3A) reveals a lower
degree of conservation in the predicted actin-binding region
Fig. 1. The main components of the vertebrate DC are conserved in Drosophila. (A) Vertebrates: the rod-like dystrophin molecule serves as a
link between the actin cytoskeleton (via its N-terminus) and the membrane (via its C-terminal regions). An interaction with L-dystroglycan pro-
vides a link with the extracellular matrix, where K-dystroglycan may associate with laminin, perlecan and agrin. Four sarcoglycans form a het-
erotetrameric transmembrane complex in close proximity to both sarcospan and L-dystroglycan. The syntrophins interact with equivalent C-ter-
minal regions on dystrophin and the dystrobrevins, which in turn interact with each other. (B) Represented by D. melanogaster, the
invertebrate DC is expected to maintain the same essential architecture. Flies possess orthologues of all major components, and interactions be-
tween dystrophin, dystroglycan, syntrophins and dystrobrevin are likely to be conserved. The £y possesses only three sarcoglycan genes, and it
is believed that the Q/N-orthologue exists as a dimer in the expected heterotetrameric sarcoglycan structure of £ies. We failed to identify a £y or-
thologue of sarcospan. Flies also possess homologues of other proteins which have been found to interact with the vertebrate DC (e.g. lami-
nins, NOS, voltage-gated sodium channels).
Fig. 2. Dendrograms of vertebrate and invertebrate DC sequences.
The dendrograms, drawn to scale with each other, are rotated so as
to display the invertebrate DC complement (represented by D. mela-
nogaster) on the left, with the corresponding vertebrate complement
(represented by Homo sapiens) on the right. The midline represents
the midpoint root of each tree, and hence the putative last common
ancestors of £ies and humans. Shaded boxes delineate the main pro-
tein families of the complex. The vertebrate system is substantially
more complex (16 versus eight proteins). We note that the topolo-
gies of the syntrophin and dystrophin/dystrobrevin trees are identi-
cal.
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(43% identity, 62% similarity) ; the C. elegans sequence is cor-
respondingly divergent (22% identity, 43% similarity). Assum-
ing that the N-termini of worm and £y dystrophins bind actin,
it is apparent that the mode of interaction is subject to fewer
evolutionary constraints than are those of the C-terminal do-
mains. Unlike the human protein, there does not appear to be
any recognisably unique basic region within the central rod
domain that may represent an alternative means of F-actin-
binding [21].
Analysis of the rod domain shows a high level of degener-
acy, and unlike the C. elegans DYS-1, the £y rod domain is
20% shorter than its human dystrophin counterpart (and 12%
shorter than utrophin). The central region of the DmDYS
rod domain departs from the canonical dystrophin-like spec-
trin repeat motif, with its characteristic tryptophan residues
[22]. Dotplot analysis (Fig. 3B) shows that any speci¢c resem-
blance between human and £y dystrophin (indicated by a
strong diagonal) is replaced for much of the rod domain by
a more generic adherence to a looser repeat motif (indicated
by the hatched box e¡ect). Finally, the ¢rst and last few
spectrin repeats of both £y and worm dystrophins show a
high degree of continuous speci¢c similarity to human dystro-
phin, suggesting a more critical role for these particular re-
peats.
Fig. 3. Selected alignments of DC protein sequences. (A) Alignment of the actin-binding N-terminal domains of human dystrophin (Hs Dys),
utrophin (Hs Utr) and DmDYS, highlighting two calponin-homologous (CH) regions (single and double underlines). Identical and similar resi-
dues are indicated (black and grey, respectively). (B) Dot matrix plot of direct comparison between full length human (vertical) and £y (hori-
zontal) dystrophin proteins (DOTTER [44]). Top left = N-termini; bottom right = C-termini. Continuous diagonal lines signify areas of speci¢c
high homology between the proteins. The central hatched region identi¢es repeat sequences sharing generic similarity along the rod domains of
both dystrophins. (C) C-terminal alignment of human Q- and N-sarcoglycans against DmSCG-QN, all proteins sharing four conserved extracellu-
lar cysteine residues. (D) C-terminal alignment of human dystroglycan against DmDG. The dystrophin-interacting polyproline motif is under-
lined. (E) The C-terminal dystrophin-interacting SU regions of human syntrophins against DmSYN-1 and DmSYN-2. (F) Human dystrobrevins
against DmDYB, with two EF-regions [20] (double- and dotted-underlined), ZZ motif (single-underlined). (G) The syntrophin-binding regions
(boxed) and conserved leucine-heptad repeats of human and Drosophila dystrobrevins. More comprehensive alignments are available at the fol-
lowing URL: http://www.kcl.ac.uk/ip/ebitimiigbaseimokumo/molecularneuroscience.html.
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4. The invertebrate DC: piece by piece
Vertebrate dystrophin is known to interact via its cysteine-
rich and C-terminal regions with K- and probably L-dystro-
brevin [23], as well as with the syntrophins (K1, L1, L2, Q1 and
Q2; [24,25]) and the transmembrane L-dystroglycan subunit
[26,27]. The sarcoglycans (K, L, Q and N) are also found span-
ning the sarcolemma in close proximity to dystroglycan and
sarcospan [28]. The high degree of conservation of the dystro-
phin C-terminus between £y and human suggested the likely
presence in £y of homologues of the proteins known to inter-
act with this region. We have subsequently cloned partial
cDNAs suggestive of coding sequences for a dystrobrevin
(DmDYB), dystroglycan (DmDG) and two syntrophins
(DmSYN-1; DmSYN-2). Similarly, putative genes for three
sarcoglycans have been found (DmSCG-KO ; DmSCG-L ;
DmSCG-QN).
In vertebrate skeletal muscle, K-, L-, Q- and N-sarcoglycans
form a heterotetrameric complex (Fig. 1A), and are of partic-
ular interest due to their involvement in human limb-girdle
muscular dystrophies [29]. The highly homologous N- and Q-
sarcoglycans in turn show signi¢cant homology to L-sarcogly-
can. K-Sarcoglycan di¡ers considerably from L, Q and N, and
in smooth muscle, K-sarcoglycan is substituted by the closely
related O-sarcoglycan [30]. We have found the sarcoglycan
family of proteins to be simpli¢ed in D. melanogaster. The
£y genome encodes a single orthologue of vertebrate K- and
O-sarcoglycans (DmSCG-KO), a L-sarcoglycan (DmSCG-L)
and a single orthologue of Q- and N-sarcoglycans (DmSCG-
QN). Given the stoichiometry of the mammalian sarcoglycan
complex, we suggest that DmSCG-QN exists as a homodimer in
association with DmSCG-KO and DmSCG-L. The DmSCG-QN
protein is the most conserved of Drosophila sarcoglycans (35%
identical, 56% similar to human Q- and N-sarcoglycans), shar-
ing a short N-terminal region, a highly conserved transmem-
brane domain (typical of type II membrane topology) and
four extracellular cysteine residues (Fig. 3C) with its human
orthologues. Similarly, DmSCG-L appears to share the same
type II characteristics as its human counterpart, although its
sequence is less conserved (19% identical, 35% similar). The
homology between DmSCG-KO and human K/O-sarcoglycans
is also quite low (18% identical, 36% similar), but the N-ter-
minal regions share a predicted signal sequence, typical of
type I transmembrane proteins.
Vertebrate dystroglycan is a dystrophin-associated protein
expressed as a large propeptide, which is later cleaved into K-
and L-subunits [31]. K-Dystroglycan retains its interactions
with the transmembranal L-subunit, and interacts with com-
ponents of the extracellular matrix. We have identi¢ed a single
orthologous sequence in D. melanogaster, which is moderately
conserved throughout the length of the protein (31% identity,
48% similarity), with a predicted transmembrane domain and
recognisable polyproline motif at the C-terminus (Fig. 3D).
This motif is a characteristic signal for WW domain-binding
and has recently been implicated in the phosphotyrosine-regu-
lated interaction with the utrophin WW domain [32]. The
region corresponding to the C-terminal (membrane-proximal)
one-third of the extracellular K-dystroglycan subunit is also
more highly conserved, and this may provide further evidence
for interactions with biglycan protein [33].
Consistent with ¢ndings in C. elegans [13,25], the £y ge-
nome contains two expressed homologues of the ¢ve verte-
brate syntrophins (DmSYN-1 and DmSYN-2). These cyto-
plasmic proteins are known to interact via their PDZ
domain with the intracellular signalling molecule nNOS [34]
and voltage-gated sodium channels [9,10], as well as with the
‘syntrophin-binding’ region of the dystrophins and dystrobre-
vins. Both DmSYN-1 and DmSYN-2 retain the characteristic
syntrophin domain structure: a PH domain interrupted by a
PDZ domain is followed by a second PH domain, with the
proteins ending C-terminal with a ‘syntrophin-unique’ (SU)
region (Fig. 3E). DmSYN-1 is more similar to human K1-,
L1- and L2-syntrophins (40% identical), and DmSYN-2 more
similar to the recently characterised human Q1- and Q2-syntro-
phins (35% identical).
The characterisation of a Drosophila homologue of dystro-
brevin completes the £y complement of known cytoplasmic
DC components. Dystrobrevin is thought to have arisen
very early in evolution through an initial duplication of the
original dystrophin ancestor [2]. The £y orthologue, DmDYB,
shows continuous similarity to its two vertebrate counterparts,
including four EF-hands and a ZZ domain (Fig. 3F), a syn-
trophin-binding region (Fig. 3G) and a high degree of con-
servation towards its N-terminus, a region postulated to in-
teract with the vertebrate sarcoglycans^sarcospan complex
[35]. The putative syntrophin-binding region contains a single
highly conserved motif shared between vertebrates and inver-
tebrates (DEEHRLIARYAARLA). As with the dystrophins,
the second coiled-coil region is more similar between phyla
and includes six conserved leucine-heptad repeats.
During this investigation, we were unable to identify a sar-
cospan homologue, despite its association with sarcoglycans
in vertebrate muscle [36]. It may be that sarcospan is a verte-
brate-speci¢c protein, or that low selective pressure has al-
lowed the £y and human sequences to diverge beyond recog-
nition (indeed, null mutations of mouse sarcospan cause no
observable phenotype [37]).
4.1. Chromosomal gene localisations and cDNA accession
numbers for Drosophila DC proteins
Localisations were extracted from database entries for ge-
nomic clones (Flybase), and have not been experimentally
con¢rmed.
Dystrophin/utrophin/DRP2 orthologue (DmDYS):
AF277386, 3R 92A6-92A7; K/L-dystrobrevins orthologue
(DmDYB): AF277387, 2R 49A5-49A7; K1/L1/L2-syntrophins
orthologue (DmSYN-1): AF277388, 3L 79A1; Q1/Q2-syntro-
phins orthologue (DmSYN-2): AF277389, 2R 53C7-53C14;
K/O-sarcoglycans orthologue (DmSCG-KO) : AF277391, 2L
29A1-29C1; L-sarcoglycan orthologue (DmSCG-L) :
AF277392, 3R 87B14-87B15; Q/N-sarcoglycans orthologue
(DmSCG-QN) : AF277393, X 2B8-2B9; dystroglycan ortho-
logue (DmDG): AF277390, 2R 52D2-52D15.
5. The simplicity of invertebrates
Our characterisation of the £y DC shows that £ies possess
essentially the same DC components as vertebrates, implying
a role of fundamental importance. Furthermore, regions and
domains known to mediate the interactions between members
of the complex are highly conserved between human and £y,
suggesting that the gross structure of the complex is identical
(Fig. 1B). Similarities between the human and £y proteins
follow the expected phylogeny (Fig. 2), and the rami¢ed
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topology of the vertebrate branches presumably relates to
signi¢cant adaptations in vertebrate evolution. Divergence of
K- and O-sarcoglycan may have coincided with the divergence
of vertebrate smooth and striated muscle, and the evolving
nervous system may have demanded newly adapted forms of
syntrophin, dystrobrevin and dystrophin (DRP2). In this lat-
ter regard, it is interesting to note that the tree topologies of
the dystrophin/dystrobrevin family and the syntrophin family
are identical. It is not known whether this re£ects coordinate
specialisation of function or merely a need for more elabo-
rately controlled spatial or temporal expression patterns. The
sarcoglycans appear to have diverged rather unequally, with
DmSCG-QN and human Q/N-sarcoglycans maintaining more
similarity. This may suggest a more critical role for Q/N-sarco-
glycans in the functioning of its heteromeric complex. Surpris-
ingly, the £y dystroglycan orthologue is very loosely con-
served, despite its essential mammalian role [38]. Serving as
a link between the extracellular matrix proteins and the cyto-
plasmic DC, dystroglycan has only one recognisable binding
motif. Its polyproline C-terminus is known to link both utro-
phin and dystrophin to the cell membrane [32,39]; it is unclear
as to what extent the primary sequence is important for direct
extracellular interactions.
The smaller number of syntrophins and dystrophin-related
proteins represents the most noticeable reduction of complex-
ity in the invertebrate DC. The vertebrate dystrophins and
syntrophins appear to have diverse but unclear roles in the
central and peripheral nervous systems, and in skeletal, car-
diac and smooth muscle. Many of these roles may have been
acquired through the elaboration of gene families, and it is
not clear which are ancestral and which are derived. Synaptic
localisation seems to be a recurring theme, with both dystro-
phin itself and DRP2 being associated with synapses in the
brain [40,41], and utrophin being localised to the neuromus-
cular junction (NMJ) [42]. Given the possible association be-
tween DRP2 and central cholinergic transmission [41], the
cholinergic nature of the NMJ (with a suggested role of dys-
troglycan in localising acetylcholinesterase [43]) and the per-
turbation of cholinergic signalling in the dystrophin-de¢cient
worm [14,16], it is conceivable that a role in cholinergic trans-
mission is ancestral in the dystrophin family, and that the
sarcolemmal association of vertebrate dystrophins is a recent
adaptation. The further identi¢cation of Drosophila proteins
orthologous to the muscle-speci¢c sarcoglycans re£ects an im-
portant aspect of the conservation of the DC that will hope-
fully shed light on relationships between ancestral and ac-
quired muscular functions.
With completion of the Drosophila genome project, the
clones reported here are likely to represent the entire Droso-
phila repertoire of proteins orthologous to the known verte-
brate DC. Their existence implies that the £y (and presumably
most metazoans) has the potential to form a complex almost
identical to the well-characterised human skeletal muscle DC.
We suggest that the reduced heterogeneity of the DC compo-
nents in this experimentally amenable organism makes it an
ideal model for resolving the fundamental ancestral role of the
DC.
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